Physician profile
Tommy Lyle Summe
NPI 1750393666
$12,578.05
in general payments reported to CMS, 2019-2025
40 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,794 · 2020: $2,670 · 2021: $2,489 · 2022: $1,938 · 2023: $1,104 · 2024: $305 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,686.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,686.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orexo US, INC. | $1,648.33 | 2019-2025 | Zubsolv |
| Astrazeneca Pharmaceuticals Lp | $1,638.57 | 2019-2024 | Breztri, Farxiga |
| Gilead Sciences, INC. | $1,144.29 | 2019-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $1,108.03 | 2019-2025 | Trulance, Xifaxan |
| Novo Nordisk INC | $959.68 | 2019-2023 | Wegovy |
| Zyla Life Sciences, INC. | $758.16 | 2019-2020 | |
| Abbvie INC. | $752.29 | 2021-2025 | Mavyret, Ubrelvy, Qulipta |
| Janssen Pharmaceuticals, INC | $592.23 | 2019-2022 | |
| Pfizer INC. | $407.91 | 2019-2021 | |
| Teva Pharmaceuticals USA, INC. | $390.43 | 2019-2022 | |
| Lilly USA, LLC | $381.64 | 2019-2022 | |
| Assertio Therapeutics, INC. | $324.58 | 2019-2020 | |
| Amarin Pharma, INC. | $313.93 | 2020-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $305.46 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $303.25 | 2019-2023 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
Show all 40 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tommy Summe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.